newsfilter
← Latest News
PR Newswire·

International Patent Application Filed for Cervical Cancer Vaccine

VANCOUVER, BC, May 2, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE:BIOV), (FRA:5LB), (OTCQB:BVAXF) ("BioVaxys" or "Company"), announced today that it has continued to expand the patent coverage for its cancer vaccine platform by filing an internat